Jason B. Daly serves as Executive at Amneal Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jason B. Daly has executed 7 insider transactions totaling $199.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2025 involved selling 22,000 shares valued at $199.1K.
Jason B. Daly currently holds 10,606 shares of Amneal Pharmaceuticals, Inc. (AMRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason B. Daly has been a net seller of AMRX stock. They have purchased $0 and sold $199.1K worth of shares.
Jason B. Daly's most recent insider trade was on Aug 12, 2025, when they sold 22,000 shares at $9.05 per share.
Get notified when new Form 4 filings are submitted
| $5.47 |
| Discretionary |
| Mar 3, 2024 | AMRX | $0 | Option Exercise | 38,226 | $N/A | Discretionary |
| Mar 3, 2024 | AMRX | $39.2K | Payment | 7,166 | $5.47 | Discretionary |
| Mar 3, 2024 | AMRX | $0 | Option Exercise | 22,645 | $N/A | Discretionary |
| Mar 3, 2023 | AMRX | $0 | Option Exercise | 22,645 | $N/A | Discretionary |
| Mar 3, 2023 | AMRX | $15.7K | Payment | 8,164 | $1.92 | Discretionary |